Biotest Aktiengesellschaft (BIO) — Working Capital to Net Assets Ratio
Biotest Aktiengesellschaft (BIO) has a Working Capital to Net Assets ratio of 123.4% as of March 2025. Working capital of €628.60 Million (current assets of €788.70 Million minus current liabilities of €160.10 Million) is measured against net assets of €509.60 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See financial flexibility index of Biotest Aktiengesellschaft to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Biotest Aktiengesellschaft Working Capital to Net Assets (2002–2024)
This chart shows how Biotest Aktiengesellschaft's Working Capital to Net Assets ratio has evolved across 20 annual periods from 2002 to 2024. As of March 2025, the ratio stands at 123.4%, reflecting working capital of €628.60 Million against net assets of €509.60 Million EUR. See BIO defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Biotest Aktiengesellschaft (2002–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Biotest Aktiengesellschaft from 2002 to 2024, covering 20 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see BIO market cap.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 122.4% | €649.40 Million | €530.70 Million | €809.50 Million | €160.10 Million | ▲ +48.0 pp |
| 2023 | 74.4% | €371.20 Million | €498.90 Million | €756.50 Million | €385.30 Million | ▼ -57.4 pp |
| 2022 | 131.8% | €489.20 Million | €371.10 Million | €619.40 Million | €130.20 Million | ▲ +22.5 pp |
| 2021 | 109.3% | €415.80 Million | €380.40 Million | €522.20 Million | €106.40 Million | ▲ +7.2 pp |
| 2020 | 102.1% | €450.70 Million | €441.60 Million | €556.30 Million | €105.60 Million | ▲ +16.6 pp |
| 2019 | 85.5% | €407.80 Million | €476.90 Million | €522.80 Million | €115.00 Million | ▲ +10.9 pp |
| 2018 | 74.6% | €369.50 Million | €495.20 Million | €495.10 Million | €125.60 Million | ▲ +17.5 pp |
| 2017 | 57.1% | €198.50 Million | €347.80 Million | €449.70 Million | €251.20 Million | ▼ -32.0 pp |
| 2016 | 89.0% | €321.20 Million | €360.70 Million | €467.20 Million | €146.00 Million | ▼ -22.8 pp |
| 2015 | 111.8% | €461.00 Million | €412.30 Million | €586.80 Million | €125.80 Million | ▼ -2.8 pp |
| 2014 | 114.6% | €550.40 Million | €480.20 Million | €679.30 Million | €128.90 Million | ▲ +19.5 pp |
| 2013 | 95.1% | €438.20 Million | €460.70 Million | €562.50 Million | €124.30 Million | ▲ +40.3 pp |
| 2012 | 54.8% | €202.58 Million | €369.43 Million | €367.46 Million | €164.88 Million | ▼ -9.3 pp |
| 2011 | 64.1% | €222.22 Million | €346.67 Million | €369.95 Million | €147.74 Million | ▲ +6.4 pp |
| 2010 | 57.7% | €177.60 Million | €307.61 Million | €308.94 Million | €131.35 Million | ▼ -7.7 pp |
| 2009 | 65.4% | €176.48 Million | €269.86 Million | €325.26 Million | €148.78 Million | ▲ +1.8 pp |
| 2008 | 63.6% | €161.15 Million | €253.37 Million | €279.49 Million | €118.34 Million | ▼ -104.3 pp |
| 2004 | 167.9% | €181.27 Million | €107.97 Million | €197.86 Million | €16.59 Million | ▼ -8.7 pp |
| 2003 | 176.6% | €182.39 Million | €103.29 Million | €197.21 Million | €14.82 Million | ▼ -2.7 pp |
| 2002 | 179.3% | €198.62 Million | €110.79 Million | €220.67 Million | €22.05 Million | — |